Small Molecules

What can we learn about outsourcing trends from the last 40 years?

Existing drugs can – and should – be repurposed to fight neglected diseases.

We need more vaccine manufacturing techniques at our disposal.

Does Penicillium contain a treasure trove of undiscovered secondary metabolites?

Is growing awareness of unwanted drug effects good or bad for patients?

We forge ahead to celebrate the fantastic individuals involved in bettering the pharma industry.

Hygiene is essential to pharma, but there are a suprising number of ways it can go wrong.

We must overcome the challenges of microparticulates to improve the patient experience.

The industry is shifting towards biopharmaceuticals, but there is still demand for synthetic APIs.

DMS could make early drug discovery cheaper, faster and more efficient.